Adrian V. S. Hill

Sir Adrian Vivian Sinton Hill, is an Irish-British vaccinologist who is Director of the Jenner Institute and Lakshmi Mittal and Family Professor of Vaccinology at the University of Oxford, an honorary Consultant Physician in Infectious Diseases, and Fellow of Magdalen College, Oxford. Hill is a leader in the field of malaria vaccine development and was a co-leader of the research team which produced the Oxford–AstraZeneca COVID-19 vaccine, along with Professor Sarah Gilbert of the Jenner Institute and Professor Andrew Pollard of the Oxford Vaccine Group. Provided by Wikipedia
Showing 1 - 20 results of 37 for search 'Adrian V. S. Hill', query time: 0.03s Refine Results
  1. 1
    Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity.

    Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity. by Naif Khalaf Alharbi, Alexandra J Spencer, Adrian V S Hill, Sarah C Gilbert

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy.

    MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy. by Susanna J Dunachie, Tamara Berthoud, Sheila M Keating, Adrian V S Hill, Helen A Fletcher

    Published 2010-09-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.

    Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy. by Angela M Minassian, Edward O Ronan, Hazel Poyntz, Adrian V S Hill, Helen McShane

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.

    Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection. by James S Cavenaugh, Dorka Awi, Maimuna Mendy, Adrian V S Hill, Hilton Whittle, Samuel J McConkey

    Published 2011-02-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Identification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profiling.

    Identification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profiling. by Julius Clemence R Hafalla, Karolis Bauza, Johannes Friesen, Gloria Gonzalez-Aseguinolaza, Adrian V S Hill, Kai Matuschewski

    Published 2013-05-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control study.

    Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control study. by Magda K Ellis, Katherine S Elliott, Anna Rautanen, Derrick W Crook, Adrian V S Hill, Stephen J Chapman

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses.

    Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses. by Anita Milicic, Randip Kaur, Arturo Reyes-Sandoval, Choon-Kit Tang, Jared Honeycutt, Yvonne Perrie, Adrian V S Hill

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.

    Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans. by Stephen M Todryk, Philip Bejon, Tabitha Mwangi, Magdalena Plebanski, Britta Urban, Kevin Marsh, Adrian V S Hill, Katie L Flanagan

    Published 2008-04-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.

    Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses. by Anna M Checkley, David H Wyllie, Thomas J Scriba, Tanya Golubchik, Adrian V S Hill, Willem A Hanekom, Helen McShane

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.

    Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A. by Kathryn T Whelan, Ansar A Pathan, Clare R Sander, Helen A Fletcher, Ian Poulton, Nicola C Alder, Adrian V S Hill, Helen McShane

    Published 2009-06-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.

    A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity. by Matthew D J Dicks, Alexandra J Spencer, Nick J Edwards, Göran Wadell, Kalifa Bojang, Sarah C Gilbert, Adrian V S Hill, Matthew G Cottingham

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination

    Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination by Katja Müller, Matthew P Gibbins, Mark Roberts, Arturo Reyes‐Sandoval, Adrian V S Hill, Simon J Draper, Kai Matuschewski, Olivier Silvie, Julius Clemence R Hafalla

    Published 2021-03-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.

    Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A. by Kristin L Griffiths, Ansar A Pathan, Angela M Minassian, Clare R Sander, Natalie E R Beveridge, Adrian V S Hill, Helen A Fletcher, Helen McShane

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.

    Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials. by Ansar A Pathan, Clare R Sander, Helen A Fletcher, Ian Poulton, Nicola C Alder, Natalie E R Beveridge, Kathryn T Whelan, Adrian V S Hill, Helen McShane

    Published 2007-10-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.

    Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain. by Alexandra J Spencer, Matthew G Cottingham, Jennifer A Jenks, Rhea J Longley, Stefania Capone, Stefano Colloca, Antonella Folgori, Riccardo Cortese, Alfredo Nicosia, Migena Bregu, Adrian V S Hill

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.

    4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques. by Alexandra J Spencer, Julie Furze, Jared D Honeycutt, Alice Calvert, Saroj Saurya, Stefano Colloca, David H Wyllie, Sarah C Gilbert, Migena Bregu, Matthew G Cottingham, Adrian V S Hill

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children.

    The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children. by George M Warimwe, Linda M Murungi, Gathoni Kamuyu, George M Nyangweso, Juliana Wambua, Vivek Naranbhai, Helen A Fletcher, Adrian V S Hill, Philip Bejon, Faith H A Osier, Kevin Marsh

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.

    Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine. by Timothy J Powell, Yanchun Peng, Tamara K Berthoud, Marie-Eve Blais, Patrick J Lillie, Adrian V S Hill, Sarah L Rowland-Jones, Andrew J McMichael, Sarah C Gilbert, Tao Dong

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein.

    T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein. by Emily K Forbes, Simone C de Cassan, David Llewellyn, Sumi Biswas, Anna L Goodman, Matthew G Cottingham, Carole A Long, Richard J Pleass, Adrian V S Hill, Fergal Hill, Simon J Draper

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Quantification of Plasmodium falciparum: validation of quantitative polymerase chain reaction assays for detection of parasites in controlled human malaria infection studies

    Quantification of Plasmodium falciparum: validation of quantitative polymerase chain reaction assays for detection of parasites in controlled human malaria infection studies by Elizabeth Kibwana, Domtila Kimani, Nick J. Edwards, Kelvias Keter, Agnes Mutiso, Lydia Nyamako, Rose Gatheru, Adrian V. S. Hill, Philip Bejon, Philip Bejon, Katie J. Ewer, Melissa C. Kapulu, Melissa C. Kapulu

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: